Patient No | Age (years) | Sex | Eye | Systemic diseases | Type of glaucoma | Number of previous operations | Site | Postoperative complications | Antiproliferative (dose (mg)) | Seidel’s test | Lens status | IOP controlled | Filtering bleb before onset | Onset of symptoms (y.mo) | Years to infection |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 58 | F | R | hyperthyroidism, HTN | Secondary | 0 | Sup | shallow chamber, corneal epithelial defects | 5-FU (50) | − | P | good | cystic, avascular | 1989.6 | 3.4 |
2 | 47 | M | L | DM | POAG | 0 | Sup | shallow chamber | 5-FU (50) | + | P | good* | cystic, avascular | 1991.11 | 4.0 |
3 | 38 | F | R | none | Developmental | 0 | Sup | none | none | + | P | good | cystic, avascular | 1993.4 | 3.9 |
4 | 15 | F | L | none | Developmental | 2 | Sup | none | MMC (0.1) | − | P | good | cystic, avascular | 1993.4 | 1.1 |
5 | 75 | M | R | HTN | NTG | 0 | Sup | wound leakage, choroidal detachment | MMC (0.1) | − | A | good | cystic, avascular | 1993.12 | 0.4 |
6 | 59 | M | R | HTN, cerebral infarction | Capsular | 2 | Inf | wound leakage | MMC (0.2) | − | P | good | cystic, avascular | 1994.4 | 2.0 |
7 | 60 | F | R | none | POAG | 4 | Inf | none | MMC (0.1) | − | P | good | cystic, avascular | 1994.5 | 2.2 |
8 | 28 | M | R | hepatitis | POAG | 0 | Sup | shallow chamber, corneal epithelial defects | 5-FU (50) | + | P | good* | cystic, avascular | 1994.5 | 6.0 |
9 | 30 | F | R | none | Secondary | 1 | Sup | wound leakage | MMC (0.2) | − | P | good | cystic, avascular | 1995.10 | 5.0 |
10 | 66 | M | R | tuberculosis | Secondary | 0 | Sup | none | MMC (0.1) | − | P | good | cystic, avascular | 1995.12 | 3.0 |
11 | 52 | M | R | DM | POAG | 0 | Sup | none | MMC (0.2) | +? | P | good | cystic, avascular | 1996.2 | 3.6 |
HTN = hypertension; DM = diabetes mellitus; POAG = primary open angle glaucoma; NTG = normal tension glaucoma; Sup = superior; Inf = inferior; 5-FU = 5-fluorouracil; MMC = mitomycin C; P = phakic; A = aphakic;* with topical eyedrops.